RxSight, Inc.
NASDAQRXST enters the week following its Q1 earnings release with a notable shift in short positioning — shorts that built aggressively through late April are now unwinding, even as the stock trades at just $7.26. Short interest has been the dominant story for RXST in recent weeks. It peaked at roughly 16.6% of the free float in early April, then briefly compressed before rebuilding to…
Snapshot as of 7 May 2026
RXST enters the week following its Q1 earnings release with a notable shift in short positioning — shorts that built aggressively through late April are now unwinding, even as the stock trades at just $7.26. Short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RXST — free to start on ORTEX.
Sign up for free →Open RXST on ORTEX